Attenuating CXCL8-CXCR1/2 signaling (via neutralizing antibodies, small molecule antagonists and pepducins) has been shown to have major inhibitory effects on tumor growth, angiogenesis and tumor dissemination. Here, CXCR1 is linked to neoplasm.